A new study has identified three psychological profiles that influence brain health, cognitive decline, and dementia risk in ...

Researchers from Singapore's National Healthcare Group (NHG)'s Institute of Mental Health (IMH) and Agency for Science, ...

Boehringer Ingelheim today announced top-line results from the Phase III CONNEX clinical program in cognitive impairment in adults with ...

The FDA has approved Cobenfy, a new drug to treat people with schizophrenia that comes with fewer side effects.

Medically reviewed by Dakari Quimby, PhD Psychosis and schizophrenia are related but distinct mental health conditions ...

Bristol Myers Squibb CEO Chris Boerner described Cobenfy, a new drug to treat schizophrenia and may also help with bipolar ...

Luna will jump on his lap and put her head against his, preventing Green from hitting his face and bringing him back to the present moment. Start the day smarter. Get all the news you need in your ...

In those with first episode psychosis, a long duration of untreated psychosis was linked to negative psychotic symptoms and lower symptom remission.

Magdalena aiming to submit Investigational New Drug (IND) application in early 2025 to the FDA for a next-generation psychoactive prescription ...

According to the Cleveland Clinic, it is “extremely common” with conditions such as schizophrenia, and prevents the brain from recognising one or more health issues – meaning the sufferer ...